Literature DB >> 32210395

Virtual memory CD8+ T cells restrain the viral reservoir in HIV-1-infected patients with antiretroviral therapy through derepressing KIR-mediated inhibition.

Jie-Hua Jin1,2,3, Hui-Huang Huang2,3, Ming-Ju Zhou2,3,4, Jing Li2,3,4, Wei Hu2,3, Lei Huang2,3, Zhe Xu2,3, Bo Tu2,3, Guang Yang2,3, Ming Shi1,2,3, Yan-Mei Jiao2,3, Xing Fan2,3, Jin-Wen Song2,3, Ji-Yuan Zhang2,3, Chao Zhang5,6, Fu-Sheng Wang7,8,9.   

Abstract

The viral reservoir is the major hurdle in developing and establishing an HIV cure. Understanding factors affecting the size and decay of this reservoir is crucial for the development of therapeutic strategies. Recent work highlighted that CD8+ T cells are involved in the control of viral replication in ART-treated HIV-1-infected individuals, but how CD8+ T cells sense and restrict the HIV reservoir are not fully understood. Here, we demonstrate that a population of unconventional CD45RA+, PanKIR+, and/or NKG2A+ virtual memory CD8+ T cells (TVM cells), which confer rapid and robust protective immunity against pathogens, plays an important role in restraining the HIV DNA reservoir in HIV-1-infected patients with effective ART. In patients undergoing ART, TVM cells negatively correlate with HIV DNA and positively correlate with circulating IFN-α2 and IL-15. Moreover, TVM cells constitutively express high levels of cytotoxic granule components, including granzyme B, perforin and granulysin, and demonstrate the capability to control HIV replication through both cytolytic and noncytolytic mechanisms. Furthermore, by using an ex vivo system, we showed that HIV reactivation is effectively suppressed by TVM cells through KIR-mediated recognition. This study suggests that TVM cells are a promising target to predict posttreatment virological control and to design immune-based interventions to reduce the reservoir size in ART-treated HIV-1-infected individuals.

Entities:  

Keywords:  HIV reservoir; KIR; virtual memory CD8+ T cells

Year:  2020        PMID: 32210395      PMCID: PMC7784989          DOI: 10.1038/s41423-020-0408-9

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  63 in total

Review 1.  Similar but different: virtual memory CD8 T cells as a memory-like cell population.

Authors:  Tabinda Hussain; Kylie M Quinn
Journal:  Immunol Cell Biol       Date:  2019-06-18       Impact factor: 5.126

2.  Functional cure of HIV: the scale of the challenge.

Authors:  Miles P Davenport; David S Khoury; Deborah Cromer; Sharon R Lewin; Anthony D Kelleher; Stephen J Kent
Journal:  Nat Rev Immunol       Date:  2019-01       Impact factor: 53.106

Review 3.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

4.  Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission?

Authors:  Deborah Cromer; Mykola Pinkevych; Thomas A Rasmussen; Sharon R Lewin; Stephen J Kent; Miles P Davenport
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

Review 5.  HLA/KIR restraint of HIV: surviving the fittest.

Authors:  Arman A Bashirova; Rasmi Thomas; Mary Carrington
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

Review 6.  Tissue reservoirs of HIV.

Authors:  Joseph K Wong; Steven A Yukl
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

7.  Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

Authors:  Liang Shan; Kai Deng; Neeta S Shroff; Christine M Durand; S Alireza Rabi; Hung-Chih Yang; Hao Zhang; Joseph B Margolick; Joel N Blankson; Robert F Siliciano
Journal:  Immunity       Date:  2012-03-08       Impact factor: 31.745

8.  Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1.

Authors:  Lies Boelen; Bisrat Debebe; Marcos Silveira; Arafa Salam; Julia Makinde; Chrissy H Roberts; Eddie C Y Wang; John Frater; Jill Gilmour; Katie Twigger; Kristin Ladell; Kelly L Miners; Jyothi Jayaraman; James A Traherne; David A Price; Ying Qi; Maureen P Martin; Derek C Macallan; Chloe L Thio; Jacquie Astemborski; Gregory Kirk; Sharyne M Donfield; Susan Buchbinder; Salim I Khakoo; James J Goedert; John Trowsdale; Mary Carrington; Simon Kollnberger; Becca Asquith
Journal:  Sci Immunol       Date:  2018-11-09

9.  Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.

Authors:  Kai Deng; Mihaela Pertea; Anthony Rongvaux; Leyao Wang; Christine M Durand; Gabriel Ghiaur; Jun Lai; Holly L McHugh; Haiping Hao; Hao Zhang; Joseph B Margolick; Cagan Gurer; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Steven G Deeks; Till Strowig; Priti Kumar; Janet D Siliciano; Steven L Salzberg; Richard A Flavell; Liang Shan; Robert F Siliciano
Journal:  Nature       Date:  2015-01-07       Impact factor: 49.962

10.  Editorial: On the Origin and Function of Human NK-Like CD8+ T Cells: Charting New Territories.

Authors:  Fernando A Arosa
Journal:  Front Immunol       Date:  2017-11-15       Impact factor: 7.561

View more
  8 in total

1.  CCL5-Secreting Virtual Memory CD8+ T Cells Inversely Associate With Viral Reservoir Size in HIV-1-Infected Individuals on Antiretroviral Therapy.

Authors:  Wei Hu; Yan-Jun Li; Cheng Zhen; You-Yuan Wang; Hui-Huang Huang; Jun Zou; Yan-Qing Zheng; Gui-Chan Huang; Si-Run Meng; Jie-Hua Jin; Jing Li; Ming-Ju Zhou; Yu-Long Fu; Peng Zhang; Xiao-Yu Li; Tao Yang; Xiu-Wen Wang; Xiu-Han Yang; Jin-Wen Song; Xing Fan; Yan-Mei Jiao; Ruo-Nan Xu; Ji-Yuan Zhang; Chun-Bao Zhou; Jin-Hong Yuan; Lei Huang; Ya-Qin Qin; Feng-Yao Wu; Ming Shi; Fu-Sheng Wang; Chao Zhang
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

2.  People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells.

Authors:  Louise E van Eekeren; Vasiliki Matzaraki; Zhenhua Zhang; Lisa van de Wijer; Marc J T Blaauw; Marien I de Jonge; Linos Vandekerckhove; Wim Trypsteen; Leo A B Joosten; Mihai G Netea; Quirijn de Mast; Hans J P M Koenen; Yang Li; André J A M van der Ven
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

3.  Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function.

Authors:  Gema Méndez-Lagares; Ning Chin; W L William Chang; Jaewon Lee; Míriam Rosás-Umbert; Hung T Kieu; David Merriam; Wenze Lu; Sungjin Kim; Lourdes Adamson; Christian Brander; Paul A Luciw; Peter A Barry; Dennis J Hartigan-O'Connor
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

Review 4.  Signals for antigen-independent differentiation of memory CD8+ T cells.

Authors:  Eliza Mari Kwesi-Maliepaard; Heinz Jacobs; Fred van Leeuwen
Journal:  Cell Mol Life Sci       Date:  2021-08-16       Impact factor: 9.261

5.  Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV.

Authors:  Marta Calvet-Mirabent; Ildefonso Sánchez-Cerrillo; Noa Martín-Cófreces; Pedro Martínez-Fleta; Hortensia de la Fuente; Ilya Tsukalov; Cristina Delgado-Arévalo; María José Calzada; Ignacio de Los Santos; Jesús Sanz; Lucio García-Fraile; Francisco Sánchez-Madrid; Arantzazu Alfranca; María Ángeles Muñoz-Fernández; Maria J Buzón; Enrique Martín-Gayo
Journal:  EBioMedicine       Date:  2022-06-02       Impact factor: 11.205

Review 6.  Hiding in Plain Sight: Virtually Unrecognizable Memory Phenotype CD8+ T cells.

Authors:  Daniel Thiele; Nicole L La Gruta; Angela Nguyen; Tabinda Hussain
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

7.  Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways.

Authors:  Jing Li; Hui-Huang Huang; Bo Tu; Ming-Ju Zhou; Wei Hu; Yu-Long Fu; Xiao-Yu Li; Tao Yang; Jin-Wen Song; Xing Fan; Yan-Mei Jiao; Ruo-Nan Xu; Ji-Yuan Zhang; Chun-Bao Zhou; Jin-Hong Yuan; Cheng Zhen; Ming Shi; Fu-Sheng Wang; Chao Zhang
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 8.  New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection.

Authors:  Marisierra Espinar-Buitrago; Ma Angeles Muñoz-Fernández
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.